Found: 12
Select item for more details and to access through your institution.
Immunogenicity Assessment of the SARS-CoV-2 Protein Subunit Recombinant Vaccine (CoV2-IB 0322) in a Substudy of a Phase 3 Trial in Indonesia.
- Published in:
- Vaccines, 2024, v. 12, n. 4, p. 371, doi. 10.3390/vaccines12040371
- By:
- Publication type:
- Article
Immunogenicity, Safety, and Efficacy of Influenza Vaccine in T2DM and T2DM with Chronic Kidney Disease.
- Published in:
- Vaccines, 2024, v. 12, n. 3, p. 227, doi. 10.3390/vaccines12030227
- By:
- Publication type:
- Article
A phase II clinical trial of a Vi-DT typhoid conjugate vaccine in healthy Indonesian adolescents and adults: one-month evaluation of safety and immunogenicity.
- Published in:
- Tropical Diseases, Travel Medicine & Vaccines, 2024, v. 10, p. 1, doi. 10.1186/s40794-023-00210-z
- By:
- Publication type:
- Article
Immunogenicity and safety of Quadrivalent Influenza HA vaccine compared with Trivalent Influenza HA vaccine and evaluation of Quadrivalent Influenza HA vaccine batch-to-batch consistency in Indonesian children and adults.
- Published in:
- PLoS ONE, 2023, v. 18, n. 8, p. 1, doi. 10.1371/journal.pone.0281566
- By:
- Publication type:
- Article
Comparison of Immunogenicity and Safety of Diphtheria–Tetanus–Pertussis–Hepatitis B– Haemophilus influenza B (Bio Farma) with Pentabio ® Vaccine Primed with Recombinant Hepatitis B at Birth (Using Different Source of Hepatitis B) in Indonesian Infants
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 498, doi. 10.3390/vaccines11030498
- By:
- Publication type:
- Article
Protectivity and safety following recombinant hepatitis B vaccine with different source of bulk compared to hepatitis B (Bio Farma) vaccine in Indonesia.
- Published in:
- Clinical & Experimental Vaccine Research, 2022, v. 11, n. 1, p. 43, doi. 10.7774/cevr.2022.11.1.43
- By:
- Publication type:
- Article
A randomized controlled trial to evaluate the effect of influenza vaccination and probiotic supplementation on immune response and incidence of influenza-like illness in an elderly population in Indonesia.
- Published in:
- PLoS ONE, 2021, v. 16, n. 12, p. 1, doi. 10.1371/journal.pone.0250234
- By:
- Publication type:
- Article
A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: a phase II preliminary report.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Safety profile of Td vaccination in Indonesian pregnant women: a post-marketing surveillance study.
- Published in:
- Medical Journal of Indonesia, 2019, v. 28, n. 4, p. 322, doi. 10.13181/mji.v28i4.3321
- By:
- Publication type:
- Article
Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine.
- Published in:
- PLoS ONE, 2019, v. 14, n. 2, p. 1, doi. 10.1371/journal.pone.0211784
- By:
- Publication type:
- Article
DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18-24 months old.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The immunogenicity, safety, and consistency of an Indonesia combined DTP-HB-Hib vaccine in expanded program on immunization schedule.
- Published in:
- 2015
- By:
- Publication type:
- journal article